Please see the full solicitation for complete information about the funding opportunity. Below is a summary assembled by the Research & Innovation Office (RIO).

Program Summary

The 2024 Innovators in Science Award will recognize a promising Early-Career Scientist for their groundbreaking work in Cancer Immunology and is intended to reward their commitment to innovative research.

Deadlines

麻豆免费版下载Internal Deadline: 11:59pm MST March 8, 2023

Sponsor Nomination Deadline: March 31, 2023

Internal Application Requirements (all in PDF format)

  • Nominator鈥檚 Rationale for Nomination (200-word maximum): Explain why the nominee has been selected as the institutional nominee based on his/her strong record of significant independent scientific contributions, career success, and promise of sustained or accelerated progress in the future.
  • Nominee鈥檚 CV
  • Nominee鈥檚 Research Summary (1,000-word maximum): Describe up to five (5) of the nominee鈥檚 most significant scientific contributions and research accomplishments. Key results, their impact on the nominee鈥檚 field of study, and the nominee鈥檚 specific role in the described work should be included. Information about the nominee鈥檚 positions, awards, and service activities should be excluded. One figure illustrating the most significant results is allowed. Citations and figure caption do not count toward the word limit.

To access the online application, visit:

Eligibility

The nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent*.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position at an听invited academic, government, or non-profit institution or equivalent.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

*In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with the policies of the institution that granted the leave) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe of up to two (2) years. Additionally, exceptions for up to four (4) years of additional clinical training (e.g. clinical residency or fellowship) will be considered on a case-by-case basis if it is deemed essential to the nominee鈥檚 current research program. Instructions regarding how to request an extension are provided in the听Requesting an Eligibility Exception听section.

Individuals in receipt of current or prior research support from Takeda Pharmaceutical Company Limited, or its affiliates, are not eligible for nomination if the research support was in excess of US$10,000 (or equivalent in local currency) and was received within the last four (4) calendar years (2019-2023).

Limited Submission Guidelines

Each institution may submit one nomination per year.

Review Criteria

  • Quality:听The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact:听The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty:听The extent to which the work challenges existing paradigms, employs innovative new methodologies or concepts, and/or pursues an original question.
  • Promise:听The extent to which the nominee has made innovative or impactful research contributions and shows exceptional promise for significant future achievement (Early Career Scientist) in the Award field.

Award Information

Number of Awards: 1

Award Amount: $200,000

听